Bogardus Medical Systems Inc

ONCOCHART

Bogardus Medical Systems, Inc. (BMSi) · Review dated 2026-10-13

No numeric amount, currency, or named plan/tier was publicly posted in the official sources checked. The official Costs and Limitations page's indexed text states that monthly, semi-annual, or annual fees are required, are outside the base service agreement, and are charged per provider; another indexed passage states annual fees are required per prescribing provider for electronic prescribing. Thus public pricing is quote/contract based rather than a posted price list.

Billing model

Contractual/quote-only. Official indexed pricing language describes recurring monthly, semi-annual, or annual provider-based fees outside the base service agreement; no dollar amount or minimum contract term was disclosed.

Fees and add-ons

Official indexed Costs and Limitations text discloses: (1) recurring monthly, semi-annual, or annual fees per provider outside the base service agreement; (2) annual e-prescribing fees per prescribing provider; and (3) one-time or per-transaction interface costs for immunization registries, cancer registries, and public-health reporting, with fees also possible where a registry assesses charges or its interface requirements require significant BMSi changes. No public amounts were found for implementation, setup, training, migration, support/maintenance, or other modules. Official product pages describe EMR/charting, charge capture, documentation, scheduling, nursing, R&V interfaces and HL7 messaging, but do not price them.

Availability and public pricing

Current U.S. availability appears possible/likely but is not fully verifiable. The vendor-owned oncochart.com domain remains reachable and has current-looking sales/demo, contact, support and employment pages; the contact page identifies BMSI Partners, Inc. in Bloomington, Indiana, with U.S. sales (405-917-0500) and ONCOCHART support (405-917-0550). ONCOCHART is still described as a radiation-oncology information system and the site invites demonstrations. The directory-era legal identity is Bogardus Medical Systems, Inc. (BMSi), while the live contact page uses BMSI Partners, Inc.; no official acquisition/renaming announcement was located, so continuity is uncertain rather than proven. Not classified as discontinued, but product age/content and lack of dated commercial terms make lifecycle confidence limited.

Qualifications

The official Costs and Limitations, homepage, overview and support URLs intermittently failed full text extraction (the site reported that a required part could not load); pricing conclusions rely on the official page's indexed text where noted, not on a third-party/reseller quote. No official numeric price was inferred. Current status is based on the live vendor domain, sales/demo contact and support evidence, but no dated 2026 availability statement or official corporate-continuity statement was found.